Reuters Examines IARC’s Benzene Monograph, Concerns Over Possible Understatement Of Chemical’s Cancer Risk

Reuters: WHO cancer agency “left out key findings” in benzene review
“…Reuters revealed last year how [the International Agency for Research on Cancer (IARC)], in reviewing the weedkiller glyphosate, excluded some data and findings that the chemical was not linked to cancer in people: In other words, how the agency may have overplayed evidence of carcinogenicity. In the case of benzene, [chemical engineer Melvyn Kopstein] claims IARC did not consider important evidence that exposure to the chemical is higher than IARC suggests: In other words, he argues, the agency may have underplayed potential cancer risks. The disclosures are significant because they give rare insight into IARC’s methods. The agency does not publish details of how it makes its assessments and forbids observers invited to its meetings from talking publicly about the proceedings…” (Kelland, 2/28).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.